Why is "Moderna COVID-19 vaccine" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-22 16:59:24
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax among others, is a COVID-19 vaccine developed by the American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Depending on the jurisdiction, it is authorized for use in humans aged six months, twelve years, or eighteen years and older. The Moderna COVID‑19 vaccine provides protection against COVID-19, which is caused by infection by the SARS-CoV-2 virus. A different version of the Moderna COVID-19 vaccine, sold under the brand name Mnexspike (mRNA-1283), was approved for medical use in the United States in May 2025, and in the European Union in February 2026.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
COVID-19 vaccine - Britannica
-
FDA Fully Approves Moderna’s COVID-19 Vaccine for Some Young Children - Vaccine Advisor
-
FDA grants full approval to Moderna’s Covid vaccine for children but limits eligibility - statnews.com
-
FDA Approves Moderna’s COVID-19 Vaccine For Children Aged 6 Months Through 11 Years - Contagion Live
-
Comparing the COVID-19 Vaccines: How Are They Different? - Yale Medicine
-
FDA approves Moderna COVID-19 vaccine for some children - Healio
-
EC nod for Moderna’s COVID-19 vaccine mNEXSPIKE - The Pharma Letter
-
FDA approves new Moderna COVID-19 vaccine - Axios
-
If You Have a Skin Reaction to the Moderna COVID-19 Vaccine, Don't Panic - Verywell Health
-
Moderna's COVID-19 Vaccine Update Boosts Antibodies 16-Fold, Data Shows - Yahoo Finance
-
UCH opens Moderna COVID-19 vaccine trial focused on recruiting minorities - UCHealth
-
New Moderna COVID-19 vaccine approved by FDA for adults 65 and older - CBS News
-
FDA Approves New Moderna COVID-19 Vaccine mNEXSPIKE - PharmTech.com
-
FDA Approves New Moderna COVID-19 Shot - Infectious Disease Special Edition
-
FDA gives full approval to Moderna COVID shot for at-risk kids - The Hill
-
FDA OKs new Moderna COVID-19 vaccine for 65+, others with conditions - upi.com
-
FDA approves Moderna COVID-19 vaccine for high-risk children - TechTarget
-
FDA Warns of Heart Risk With Pfizer, Moderna COVID-19 Vaccines - Vaccine Advisor
-
FDA Approves Moderna’s COVID-19 Vaccine - Contagion Live
-
FDA Approves Moderna’s Next-Generation COVID-19 Vaccine mNexspike - Vaccine Advisor
-
FDA grants limited approval to new Covid vaccine from Moderna - NBC News
-
New Moderna clinical trial for children’s COVID-19 vaccines to launch in early August - UCHealth
-
04082021 - Publix moves all Florida Moderna COVID-19 vaccine scheduling to Fridays - Publix
-
Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine - National Institutes of Health (.gov)
-
FDA approves Moderna’s lower-dose COVID-19 vaccine for some - Healio
-
The Moderna COVID-19 (mRNA-1273) vaccine: what you need to know - World Health Organization (WHO)
-
Moderna COVID-19 vaccine generates long-lasting immune memory - National Institutes of Health (.gov)
-
Moderna's COVID-19 vaccine mNEXSPIKE gains FDA approval - TechTarget
-
Study finds Moderna’s COVID-19 vaccine safe and effective for young children - Vanderbilt Health News
-
County Receives Its First Shipment of Moderna COVID-19 Vaccine - San Diego County News Center
-
Peer-reviewed report on Moderna COVID-19 vaccine publishes - National Institutes of Health (.gov)
-
EMA receives application for conditional marketing authorisation of Moderna COVID-19 vaccine - ema.europa.eu
-
Moderna COVID-19 vaccine spurs lasting immune response - La Jolla Institute
-
Moderna’s Covid-19 vaccine is strongly effective, early look at data show - statnews.com
-
First data for Moderna Covid-19 vaccine show it spurs an immune response - statnews.com
-
FDA grants full approval to Moderna COVID-19 vaccine - American Hospital Association
-
How Moderna’s Vaccine Works (Published 2022) - The New York Times
-
First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021 | MMWR - Centers for Disease Control and Prevention | CDC (.gov)
-
FDA advisory panel endorses Moderna’s Covid-19 vaccine, clearing way for authorization - statnews.com
-
Additional manufacturing capacity for Moderna’s COVID-19 vaccine - ema.europa.eu
-
Rutgers Selected as Site for COVID-19 Vaccine Clinical Trial - Rutgers University
-
Nimitz Sailors Receive First Dose of Moderna COVID-19 Vaccine - navy.mil
-
NASEM releases evidence review on COVID-19 vaccine safety - American Hospital Association
-
Moderna’s latest COVID-19 vaccine is both approved and ‘made in Canada’ - Global News
-
CDC reports on allergic reactions to Moderna COVID-19 vaccine - American Hospital Association
-
U.S. gives full approval to Moderna’s COVID-19 vaccine - WHYY
-
Moderna's COVID-19 Vaccine Candidate Gets More Good News : Shots - Health News - NPR
-
How Much Could COVID-19 Vaccines Cost the U.S. After Commercialization? - KFF
-
COVID-19 Vaccine Second-Dose Completion and Interval Between ... - Centers for Disease Control and Prevention | CDC (.gov)
-
FDA advisers back Moderna's COVID-19 vaccine for older children - PBS
-
Moderna’s COVID-19 vaccine to roll out across the US - C&EN
-
Trial of Moderna Covid-19 vaccine delayed, investigators say, but July start still possible - statnews.com
-
Early data show Moderna Covid-19 vaccine generates immune response - statnews.com
-
Moderna’s COVID-19 Vaccine Safest For Older People - healthpolicy-watch.news
-
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine - The New England Journal of Medicine
-
Quarter-dose of Moderna COVID vaccine still rouses a big immune response - Nature
-
FDA verifies safety, efficacy data for Moderna COVID-19 vaccine candidate - American Hospital Association
-
Moderna COVID-19 Vaccine Authorized, May Begin Innoculations Monday - respiratory-therapy.com
-
FDA clarifies Moderna COVID-19 vaccine dosage for children under 12 - American Hospital Association
-
FDA gives Moderna COVID-19 vaccine full approval for use in ages 18 and older - Arizona Department of Health Services (.gov)
-
CDC reports rare allergic reactions to Moderna’s Covid-19 vaccine - statnews.com
-
‘Rapid and Strong’ Immune Response from Moderna COVID-19 Vaccine Candidate - respiratory-therapy.com
-
VUMC researchers involved in developing Moderna’s COVID-19 vaccine featured in Smithsonian exhibit - Vanderbilt Health News
-
Early data on Moderna COVID-19 vaccine candidate shows 94.5% efficacy - American Hospital Association
-
He experienced a severe reaction to Moderna’s Covid-19 vaccine candidate. He’s still a believer - statnews.com
-
VUMC-led study finds Moderna COVID vaccine safe and effective for children - Vanderbilt Health News
-
Moderna COVID-19 vaccine for ages 6 months-5 years available June 29 - Lexington-Fayette County Health Department
-
A researcher's perspective on the Moderna COVID-19 vaccine - uclahealth.org
-
Finland joins Sweden and Denmark in limiting Moderna COVID-19 vaccine - Reuters
-
COVID-19 Vaccine developer Kizzmekia Corbett to visit University for Discover Science lecture April 28 - University of Nevada, Reno
-
Why experts are cautious about Moderna's COVID-19 vaccine trial - PBS
-
FDA scientists endorse Moderna Covid-19 vaccine, as documents provide new hints on efficacy - statnews.com
-
FAQ Moderna Vaccine: Who should not, Side-effects - MedPark Hospital
-
Racial Diversity within COVID-19 Vaccine Clinical Trials: Key Questions and Answers - KFF
-
F.D.A. Panel Endorses Moderna’s Covid-19 Vaccine (Published 2020) - The New York Times
-
Alumni in Action: Chris Adamik ’20 helps develop Moderna’s COVID-19 vaccine - Elon University
-
Moderna COVID-19 booster may protect against variants - National Institutes of Health (.gov)
-
Moderna COVID-19 vaccine patent dispute headed to court, U.S. NIH head says - Reuters
-
EU agency moves forward meeting on Moderna COVID-19 vaccine - PBS
-
NIH clinical trial evaluating Moderna COVID-19 variant vaccine begins - National Institutes of Health (.gov)
-
Tulane University, Children’s Hospital launch Moderna Covid-19 vaccine trial for children from 6 months to 11 years old - Tulane University News
-
Moderna COVID-19 Vaccine: A New Player in Vaccine-Induced Thrombosis Without Thrombocytopenia - Cureus
-
WHO approves Moderna’s COVID-19 vaccine for emergency use - Al Jazeera
-
WATCH: Vice President-elect Kamala Harris gets Moderna COVID-19 vaccine - PBS
-
Pfizer convinces US Patent Office to cancel two Moderna COVID-19 vaccine patents - Reuters
-
De novo podocytopathy following moderna COVID-19 vaccine: A case report and racial disproportionality in adverse effect reports - Frontiers
-
First Fenway Health Staff Members Receive Moderna COVID-19 Vaccine - Fenway Health
-
UAE approves Moderna COVID-19 vaccine for emergency use - Reuters
-
Sweden, Denmark pause Moderna COVID-19 vaccine for younger age groups - Reuters
-
Moderna's Covid-19 Vaccine, Explained (Published 2020) - The New York Times
-
Pfizer, BioNTech challenge Moderna COVID-19 vaccine patents at US Patent Office - Reuters
-
Moderna’s COVID-19 Vaccine Candidate 94.5% Effective - respiratory-therapy.com
-
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel - The New England Journal of Medicine
-
Age 5-11 COVID Vaccine: Everything You Need to Know on Safety, Efficacy, and Distribution - University of Rochester Medical Center
-
UK approves Moderna’s COVID-19 vaccine for use - Al Jazeera
-
Moderna COVID-19 vaccine appointments offered at Georgia, South Carolina and Virginia Publix pharmacies - Publix
-
FDA advisers approve COVID-19 vaccine shots for kids under 5 - PBS
-
UNITED STATES DONATES THREE MILLION ADDITIONAL DOSES OF THE MODERNA COVID-19 VACCINE TO PAKISTAN - U.S. Embassy & Consulates in Pakistan (.gov)
-
German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent - Reuters
-
Rare heart-related side effects higher with Moderna COVID vaccine - cidrap.umn.edu
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.